Respiratory Syncytial Virus Prevention
4 clinical trials · Condition
◉ Watch Respiratory Syncytial Virus Prevention
| Record | Firm | Date |
|---|---|---|
| A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants (NCT05242432) | Janssen Pharmaceutical K.K. | 2022-04-01 |
| A Study of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years (NCT05101486) | Janssen Vaccines & Prevention B.V. | 2021-11-01 |
| A Study Evaluating the Immunogenicity of Different Clinical Trial Materials of Ad26.RSV.preF- Based Vaccine in Adults Aged 60 - 75 Years Old (NCT05083585) | Janssen Vaccines & Prevention B.V. | 2021-10-08 |
Track Respiratory Syncytial Virus Prevention automatically
Every clearance here is in the API, with alerts when new ones post.